1-4 of 4
Philip A. Cole
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734

Chevaun D. Morrison-Smith, Tatiana M. Knox, Ivona Filic, Kara M. Soroko, Benjamin K. Eschle, Margaret K. Wilkens, Prafulla C. Gokhale, Francis Giles, Andrew Griffin, Bill Brown, Geoffrey I. Shapiro, Beth E. Zucconi, Philip A. Cole, Madeleine E. Lemieux, Christopher A. French
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (7): 1406–1414.
https://doi.org/10.1158/1535-7163.MCT-20-0087
Published: 02 July 2020
View article titled, Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734
Open the PDF for Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734 in another window
Includes: Supplementary data
Journal Articles

Abstract PR02: Targeting PI3K: The PIP2 binding site

Michelle Miller, Oleg Schmidt-Kittler, David M. Bolduc, Evan T. Brower, Daniele Chaves-Moreira, Marc Allaire, Kenneth W. Kinzler, Ian G. Jennings, Philip E. Thompson, Philip A. Cole, L. Mario Amzel, Bert Vogelstein, Sandra B. Gabelli
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2015) 14 (7_Supplement): PR02.
https://doi.org/10.1158/1538-8514.PI3K14-PR02
Published: 06 July 2015
View article titled, Abstract PR02: Targeting PI3K: The PIP2 binding site
Journal Articles

Abstract PL03-03: Designing p300/CBP histone acetyltransferase inhibitors for cancer.

Philip A. Cole
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): PL03-03.
https://doi.org/10.1158/1535-7163.TARG-13-PL03-03
Published: 01 November 2013
View article titled, Abstract PL03-03: Designing p300/CBP histone acetyltransferase inhibitors for cancer.
Journal Articles

Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines

Frédéric R. Santer, Philipp P.S. Höschele, Su Jung Oh, Holger H.H. Erb, Jan Bouchal, Ilaria T. Cavarretta, Walther Parson, David J. Meyers, Philip A. Cole, Zoran Culig
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2011) 10 (9): 1644–1655.
https://doi.org/10.1158/1535-7163.MCT-11-0182
Published: 07 September 2011
View article titled, Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines
Open the PDF for Inhibition of the Acetyltransferases p300 and CBP Reveals a Targetable Function for p300 in the Survival and Invasion Pathways of Prostate Cancer Cell Lines in another window
Includes: Supplementary data